Stay updated with breaking news from Brain Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global Medical Enzymes Market 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global medical enzymes market is...
Using proprietary genome editing technology, Brain Biotech and Formo are collaborating to produce bioidentical milk protein.
Sweegen will expand its high-intensity sweeteners portfolio early next year with the addition of brazzein, an ultra-sweet tasting protein found in small quantities in the fruit of a West African plant called oubli, that can be produced on a commercial scale via microbial fermentation.
Sweegen will expand its high-intensity sweeteners portfolio early next year with the addition of brazzein, an ultra-sweet tasting protein found in small quantities in the fruit of a West African plant called oubli, that can be produced on a commercial scale via microbial fermentation.
Sweegen will expand its high-intensity sweeteners portfolio early next year with the addition of brazzein, an ultra-sweet tasting protein found in small quantities in the fruit of a West African plant called oubli, that can be produced on a commercial scale via microbial fermentation.